Dr. Christian Pagnoux, MD, MS, MPH
Claim this profileMount Sinai Hospital
Studies Granulomatosis with Polyangiitis
Studies Systemic Vasculitis
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Christian Pagnoux, MD, MS, MPH is currently running
Abatacept
for Giant Cell Arteritis
This randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or relapsing GCA within 8 weeks prior to screening will be randomized at a 1:1 ratio to receive subcutaneous abatacept 125mg/week or placebo. Patients who achieve remission will remain on their blinded assignment for 12 months at which time abatacept/placebo will be stopped. Patients who do not achieve remission by Month 3, who experience a relapse within the first 12 months will have the option of receiving open-label abatacept for a maximum of 12 months.
Recruiting1 award Phase 36 criteria
Depemokimab vs Mepolizumab
for Granulomatosis with Polyangiitis
This trial is testing two medications, depemokimab and mepolizumab, to see if they can help adults with a difficult-to-treat inflammatory condition called EGPA by reducing inflammation. Mepolizumab was previously approved for the treatment of EGPA.
Recruiting1 award Phase 38 criteria
More about Christian Pagnoux, MD, MS, MPH
Clinical Trial Related9 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Christian Pagnoux, MD, MS, MPH has experience with
- Abatacept
- Placebo
- Prednisone
- One-Time DNA Study
- Depemokimab
- Mepolizumab
Breakdown of trials Christian Pagnoux, MD, MS, MPH has run
Granulomatosis with Polyangiitis
Systemic Vasculitis
Wegener's Granulomatosis
Giant Cell Arteritis
Polymyalgia Rheumatica
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christian Pagnoux, MD, MS, MPH specialize in?
Christian Pagnoux, MD, MS, MPH focuses on Granulomatosis with Polyangiitis and Systemic Vasculitis. In particular, much of their work with Granulomatosis with Polyangiitis has involved treating patients, or patients who are undergoing treatment.
Is Christian Pagnoux, MD, MS, MPH currently recruiting for clinical trials?
Yes, Christian Pagnoux, MD, MS, MPH is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Christian Pagnoux, MD, MS, MPH has studied deeply?
Yes, Christian Pagnoux, MD, MS, MPH has studied treatments such as Abatacept, Placebo, Prednisone.
What is the best way to schedule an appointment with Christian Pagnoux, MD, MS, MPH?
Apply for one of the trials that Christian Pagnoux, MD, MS, MPH is conducting.
What is the office address of Christian Pagnoux, MD, MS, MPH?
The office of Christian Pagnoux, MD, MS, MPH is located at: Mount Sinai Hospital, Toronto, Ontario M5T 3L9 Canada. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.